137 related articles for article (PubMed ID: 10582666)
1. The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.
Wilson JC; Zhu JJ; Black PM
J Neurooncol; 1999 Aug; 44(1):35-9. PubMed ID: 10582666
[No Abstract] [Full Text] [Related]
2. Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.
Tanaka C; Yoshimoto K; Yang P; Kimura T; Yamada S; Moritani M; Sano T; Itakura M
J Clin Endocrinol Metab; 1997 Sep; 82(9):3141-7. PubMed ID: 9284759
[TBL] [Abstract][Full Text] [Related]
3. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of p21 and p27 genes in human pituitary adenomas.
Ikeda H; Yoshimoto T; Shida N
Br J Cancer; 1997; 76(9):1119-23. PubMed ID: 9365157
[TBL] [Abstract][Full Text] [Related]
5. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
[TBL] [Abstract][Full Text] [Related]
7. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
8. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor loss in pituitary tumors.
Alexander JM
Brain Pathol; 2001 Jul; 11(3):342-55. PubMed ID: 11414476
[TBL] [Abstract][Full Text] [Related]
11. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K
Cell; 1996 May; 85(5):707-20. PubMed ID: 8646779
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
[TBL] [Abstract][Full Text] [Related]
14. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
Fero ML; Rivkin M; Tasch M; Porter P; Carow CE; Firpo E; Polyak K; Tsai LH; Broudy V; Perlmutter RM; Kaushansky K; Roberts JM
Cell; 1996 May; 85(5):733-44. PubMed ID: 8646781
[TBL] [Abstract][Full Text] [Related]
15. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
16. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
18. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
19. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
20. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
Sui L; Tokuda M; Ohno M; Hatase O; Hando T
Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]